Although biocatalytic transformation has shown great promise in chemical synthesis, there remain significant challenges in controlling high selectivity without the formation of undesirable by-products. For instance, few attempts to construct biocatalysts for de novo synthesis of pure flavin mononucleotide (FMN) have been successful, due to riboflavin (RF) accumulating in the cytoplasm and being secreted with FMN. To address this problem, we show here a novel biosynthesis strategy, compartmentalizing the final FMN biosynthesis step in the periplasm of an engineered Escherichia coli strain. This construct is able to overproduce FMN with high specificity (92.4% of total excreted flavins). Such a biosynthesis approach allows isolation of the final biosynthesis step from the cytoplasm to eliminate undesirable byproducts, providing a new route to develop biocatalysts for the synthesis of highpurity chemicals. IMPORTANCE The periplasm of Gram-negative bacterial hosts is engineered to compartmentalize the final biosynthesis step from the cytoplasm. This strategy is promising for the overproduction of high-value products with high specificity. We demonstrate the successful implementation of this strategy in microbial production of highly pure FMN.
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S ynthetic biology and metabolic engineering approaches have been used successfully to produce a wide range of value-added products (1) (2) (3) (4) (5) (6) (7) (8) . Most efforts in biosynthesis have focused on the establishment and optimization of metabolic fluxes toward the targeted product in the cytoplasm, before excretion or extraction (9) (10) (11) (12) . The product line of available biocatalysts is limited by current strategies, especially when the targeted compound is structurally similar to other metabolites, which complicates the downstream processes for purification.
Flavin mononucleotide (FMN) is a high-value chemical that is widely used as a food additive (13) , a pharmaceutical agent (14) , an energy storage material in rechargeable batteries (15, 16) , and an electron shuttle (17) (18) (19) for some exoelectrogens functioning in bioelectrochemical systems. Currently, the industrial production of FMN is achieved by a combination of biotechnological and chemical techniques (see Fig. S1 in the supplemental material), while the commercial FMN products are extremely expensive and always of low purity (Ն70%) (20) . High-purity riboflavin (RF), the precursor of FMN, is produced by engineered microbes at low cost (21) . RF is then chemically transformed to FMN with phosphorylating reagents (22) . Due to the nonspecificity of the phosphorylation reaction, several by-products are generated, including isomeric RF monophos-phates, RF bisphosphates, and RF multiphosphates, as well as residual RF (20, 23) . Because of the similarity in chemical structures and properties of FMN and the by-products, FMN purification from the resultant chemical pool has been challenging and costly, which leads to a dramatic price increase and purity decrease from RF precursor to FMN (Fig. S1 ).
Biosynthesis based on cellular metabolism has unparalleled advantages over chemical processes, in that reactions are highly specific and precise (24) . Attempts have been made to develop FMN biocatalysts (25) (26) (27) . However, the ubiquitous presence of bifunctional RF kinase/flavin adenine dinucleotide (FAD) synthase in prokaryotes, which catalyzes the transformation from RF to the FMN intermediate and then to FAD, renders it very challenging to engineer cells to accumulate FMN in bacterial cytoplasm, with subsequent excretion (28, 29) . To address this issue, a eukaryotic gene encoding a monofunctional RF kinase was overexpressed in Candida famata, resulting in FMN accumulation in the cytoplasm and excretion (25, 30) . However, this effort could achieve only 60 to 80% FMN purity, with a considerable amount of RF also accumulating in the cytoplasm and being excreted along with FMN (25) . Since there is only one step between RF and FMN, attempts to overaccumulate FMN in the cytoplasm will inevitably lead to a relatively small portion of RF being accumulated and excreted along with FMN. Therefore, production of high-purity FMN remains challenging. The objective of this study is to establish a novel biosynthesis approach by engineering the host strain to compartmentalize the final step of FMN biosynthesis in the periplasm so as to enable the production of high-purity FMN.
The coexistence of RF and FMN in the cytoplasm is the main reason for the low purity of microbially produced FMN. Herein, we design a novel FMN biosynthesis pathway in Escherichia coli, in which FAD rather than FMN is overproduced in the cytoplasm, while the conversion of FAD to FMN occurs in the periplasm (Fig. 1 ). Based on a synthetic RF biosynthesis pathway introduced into the E. coli host (31), an exogenous bifunctional RF kinase/FAD synthase is expressed to convert cytoplasmic RF to FAD. A heterologous, highly specific, inner membrane (IM) FAD exporter is used to export FAD to the periplasm, and then a heterologous periplasmic 5=-nucleotidase catalyzes the transformation of FAD to FMN, which is excreted to the cell exterior, presumably by diffusion through outer membrane (OM) porins. Ascribed to the unique arrangement of the final FMN catalytic step in the periplasm instead of the cytoplasm, unprecedented high-purity FMN (Ͼ90% of total excreted flavins) in the spent medium was achieved prior to any form of downstream processing.
RESULTS AND DISCUSSION
Manipulation of the intracellular flavin pool. To integrate the aforementioned synthetic pathway into E. coli, a two-plasmid system was used. The pSB3C5 vector, with a p15A origin and lac promoter, was applied to overexpress cytoplasmic proteins, and the pSB4K5 vector with pSC101 origin and tet promoter was adopted to overexpress membrane and periplasmic enzymes. For ease of description, these two expression vectors are referred to as lac and tet, respectively. The cytoplasmic flavin pool of E. coli was manipulated by the heterologous enzymes RibADEH and RibC derived from Bacillus subtilis (Fig. 2 ). The intracellular flavin content of the wild-type E. coli containing empty vectors (referred to as lacϩtet) was at a low level (0.08 Ϯ 0.01 mol/g protein) and was mainly composed of FMN and FAD. A synthetic RF synthesis pathway containing ribADEH from B. subtilis (31) was inserted into the lac vector, forming the resultant plasmid A4. Upon introduction of the RF synthesis pathway, the flavin pool of recombinant E. coli (referred to as A4ϩtet) increased Ͼ3-fold, and the intracellular RF and FMN levels were also greatly enhanced (from ϳ0 to 0.14 Ϯ 0.04 mol/g protein and from 0.07 Ϯ 0.00 to 0.21 Ϯ 0.03 mol/g protein, respectively). To effectively channel intracellular RF toward FMN synthesis, a ribC gene encoding bifunctional RF kinase/FAD synthase derived from B. subtilis was added into the RF synthesis pathway; the lac vector harboring ribADEH and ribC was named A5. Comparing the flavin content of recombinant E. coli A5ϩtet with that of A4ϩtet, the high levels of intracellular flavin remained intact, while RibC successfully converted cytoplasmic RF to FAD. This indicates that the heterologous RibC from B. subtilis is effective in controlling the profile of the intracellular flavin pool, with minimal RF.
Compartmentalization of the final FMN biosynthesis step in the periplasm. The periplasmic catalytic machinery was constructed by introducing the IM FAD transporter (a) The periplasm of the bacterial host is engineered to compartmentalize the final biosynthesis step from the cytoplasm. This strategy is effective for the overproduction of valuable chemicals with high selectivity. This strategy is implemented in microbial production of highly pure FMN. (b) First, a synthetic riboflavin (RF) biosynthesis pathway, including RibADEH from Bacillus subtilis, that generates RF from GTP and ribulose 5-phosphate (R5P) is introduced into the Escherichia coli host. In order to eliminate the presence of cytoplasmic RF, the bifunctional RF kinase/flavin adenine dinucleotide (FAD) synthase RibC from B. subtilis is incorporated to convert cytoplasmic RF to FAD. Then, the heterologous inner membrane (IM) FAD exporter SO0702 from Shewanella oneidensis channels cytoplasmic FAD into the periplasmic space. Finally, FMN is overproduced from FAD in the periplasm via the heterologous periplasmic 5=-nucleotidase UshA from Shewanella oneidensis and diffuses to the cell exterior through outer membrane (OM) porins. Highly pure FMN with a minimal presence of RF could be produced with this novel biosynthesis approach by harnessing the periplasm to catalyze the final step in the biosynthesis of FMN to avoid the generation of by-products.
FIG 2
Description of the double vectors in different engineered E. coli strains and their corresponding intracellular and periplasmic flavin contents. (a) Double plasmids were used in E. coli to construct the synthetic pathways. The pSB3C5 vector with p15a origin and lac promoter (referred to as the lac vector) was used to overexpress cytoplasmic proteins, and the pSB4K5 vector with pSC101 origin and tet promoter (referred to as the tet vector) was used to overexpress membrane and periplasmic enzymes. The designations for different engineered E. coli strains are shown on the left, and their corresponding vectors are indicated on the right. (b) The intracellular flavin contents, including RF, FMN, and FAD, of different engineered E. coli strains were tested after aerobic growth for 48 h in modified M9 medium containing 15 g/liter xylose. (c) The periplasmic fraction of E. coli cells was isolated using an osmotic shock method, and the corresponding flavin contents were normalized to whole-cell total protein levels. Data are presented as means Ϯ standard deviations (n ϭ 3). SO0702 (32) and the periplasmic 5=-nucleotidase UshA (33), originating from Shewanella oneidensis MR-1, into E. coli A5ϩtet. The plasmid with SO0702 and ushA genes incorporated into the tet vector is referred to as B2 ( Fig. 2a ). Recombinant E. coli containing the heterologous gene ushA exhibited a strong enzyme activity for FAD hydrolysis in its periplasm, confirming that the introduced UshA was located in the periplasm of the E. coli host (see Fig. S2 in the supplemental material) (33) . Comparing the intracellular flavin pattern of recombinant E. coli A4ϩB2 with that of A4ϩtet ( Fig.  2b ), no significant changes in flavin content or profile were revealed, confirming that the heterologous IM FAD exporter SO0702 was highly specific for FAD. Compared with A4ϩtet, A4ϩB2 showed a relatively lower level of RF in the periplasmic space (as shown in Fig. 2c ), suggesting that the expression of SO0702 in A4ϩB2 possibly caused a decrease in RF export from the cytoplasm to the periplasm. When the pathway regulating the intracellular flavin pool was combined with this periplasmic catalytic machinery, the intracellular flavin content of E. coli A5ϩB2 was further elevated by 104.5%, in comparison with that of E. coli A5ϩtet, and was greatly dominated by FMN. Moreover, the significant increase in the intracellular flavin content was mainly attributed to the elevated FMN level in the periplasmic space of E. coli A5ϩB2 (Fig. 2c ). This indicates that the cytoplasmic FAD produced by RibADEH and RibC is efficiently exported by SO0702 into the periplasm, where it is catalyzed to FMN by the downstream enzyme UshA in E. coli A5ϩB2. Diffusion of FMN across the OM of E. coli A5ϩB2 could possibly be the rate-limiting step for FMN overproduction, as the ratio of periplasmic FMN to excreted FMN in the spent medium of A5ϩB2 was significantly lower than that of periplasmic RF to excreted RF for A4ϩtet ( Fig. 2c and 3) .
FMN-producing performance of the recombinant strain. To evaluate the performance of our recombinant E. coli harboring this novel FMN synthesis pathway, all of the E. coli strains were aerobically cultured for 48 h in shake flasks, in modified M9 medium containing 15 g/liter xylose, and their FMN productivities were compared ( Fig. 3) . For E. coli lacϩtet, only 2.1 Ϯ 0.3 M flavins were produced, with 24.3% being FMN. After introduction of the RF synthesis pathway, 215.1 Ϯ 6.8 M flavins were excreted into the medium, with 7.2% being FMN. For A4ϩB2, due to the low cytoplasmic FAD level, there was little increase in FMN production. After introduction of RibC to shift the cytoplasmic flavin pool to FAD and FMN, the percentage of FMN in the total extracellular flavin pool of E. coli A5ϩtet was increased to 83.4%, while the overall flavin concentration was severely decreased by 53.7%, compared with that of E. coli A4ϩtet. This result indicates that the FMN excretion efficiency of the intrinsic IM FMN exporter (34) in E. coli is low. When both the regulated cytoplasmic flavin profile and the periplasmic catalytic machinery were present in E. coli A5ϩB2, the highest FMN yield and purity were achieved ( Fig. 3 and Table 1 ). The extracellular FMN fraction of the final strain A5ϩB2 was as high as 92.4%, and 148.0 Ϯ 1.4 M FMN, of the 162.7 Ϯ 1.4 M total flavins, was produced. These results demonstrate that our design was successful in achieving microbial production of high-purity FMN, and we achieved the highest titer of FMN in E. coli that has yet been reported.
Influence of the synthetic FMN pathway on the host cells. In our novel FMN biosynthesis strategy, the final catalytic step for FMN generation is compartmentalized into the periplasm, in order to enhance selectivity in chemical synthesis and product secretion. The influences of such methods on the cell growth and energy metabolism were further investigated. As shown in Fig. 4a , the growth rate of the recombinant A5ϩB2 strain was slightly lower than that of the control lacϩtet strain, which is reasonable, considering the greater growth burden brought by the synthetic FMN biosynthesis pathway (35) . In addition, no obvious differences in the xylose consumption rates of the FMN-producing strain and wild-type E. coli were observed (Fig. 4b) . As a result of energy dissipation in the biosynthesis of RF or FMN, both A4ϩtet and A5ϩB2 strains showed decreased levels of intracellular ATP, in comparison with that of the wild-type E. coli. However, the intracellular ATP level of A5ϩB2 was comparable to that of A4ϩtet, indicating that the IM FAD exporter and periplasmic catalytic machinery had no significant impact on cell respiration (Fig. 4c ). These results demonstrate that this new FMN biosynthesis approach is superior in selectivity with no significant sacrifice in cell growth or respiration of the recombinant cells.
Conclusion. Our work demonstrates microbial production of highly pure FMN, which establishes a platform capable of being easily applied to various industrial RF-producing bacteria to develop more efficient producers for high-purity FMN. In addition, the periplasm is engineered to catalyze the final biosynthesis step of a specific chemical to avoid the generation of by-products. It should be pointed out that such a design concept, which considers the optimal spatial organization of synthetic path- ways, not only is powerful in solving the technical hurdles encountered during the construction of high-purity FMN producers but may also greatly facilitate the development of microbial factories for other high-value chemicals.
MATERIALS AND METHODS
In vitro gene synthesis. The ribADEH genes from B. subtilis, with optimized codons for expression in E. coli, were developed in our previous work (31) . The ribC gene from B. subtilis and SO0702 and ushA from S. oneidensis were synthesized in this work with similar methods. All of the genes with codons adapted for expression in E. coli were synthesized as biobricks, and each biobrick was flanked by an upstream prefix (containing EcoRI and XbaI sites), a ribosome-binding site (BBa_B0034; iGEM) 6 bp ahead of the start codon, and a downstream suffix (containing SpeI and SbfI sites). The primer sets for in vitro gene synthesis of ribC, SO0702, and ushA are presented in Table 2 .
Plasmid construction. All plasmid constructions were implemented in E. coli DH5␣. The ribA, ribD, ribE, and ribH biobricks were inserted into the vector pSB3C5 sequentially, two Plac promoters (BBa_R0011; iGEM) were placed ahead of ribA and ribE, and the resulting expression plasmid was named A4. A synthesized ribC biobrick was then incorporated into A4 downstream of ribH, forming the expression plasmid A5. The control vector with only one Plac promoter inserted into pSB3C5 was named the lac vector. One Ptet promoter (BBa_R0040; iGEM) and synthesized SO0702 and ushA were inserted into pSB4K5 (iGEM) sequentially, forming the plasmid B2. The empty vector with one Ptet promoter in pSB4K5 was named the tet vector. Double plasmids derived from pSB3C5 and pSB4K5 were electroporated into the host E. coli BL21-Gold (DE3). E. coli strains were cultured in LB medium at 37°C at 200 rpm. Whenever needed, 50 g/ml kanamycin or 34 g/ml chloramphenicol was added to the culture medium.
Culture conditions for FMN production. E. coli strains from Ϫ80°C freezer stocks were inoculated into 20 ml of LB broth supplemented with 50 g/ml kanamycin and 34 g/ml chloramphenicol and grown aerobically overnight at 37°C, with shaking. Then 0.4 ml E. coli suspension was centrifuged and resuspended in 10 ml of modified M9 medium (12 g/liter Na 2 HPO 4 , 6 g/liter KH 2 PO 4 , 0.5 g/liter NaCl, 1 g/liter NH 4 Cl, 0.24 g/liter MgSO 4 , 11.1 mg/liter CaCl 2 , 2 g/liter urea) supplemented with 15 g/liter xylose, 1% vitamin stock solution (36), 1% mineral stock solution (36), 1% amino acid stock solution (36), 50 g/ml kanamycin, 34 g/ml chloramphenicol, 0.01 mM isopropyl-␤-D-thiogalactoside (IPTG), and 10 nM anhydrotetracycline (aTc), in a 100-ml shake flask. Xylose was used as the carbon source because ribulose 5-phosphate, an intermediate of xylose isomerization, is one of the precursors for flavin synthesis, which facilitates flavin production. After growth at 37°C for 48 h at 200 rpm, the supernatant was subjected to flavin and xylose measurement, and the cell pellet was collected for extraction of intracellular flavin and periplasmic flavin. The biomass concentration was indicated as the total protein concentration.
Extraction of intracellular and periplasmic flavin. The intracellular flavin pool was isolated as described previously (37) . Briefly, cell pellets from 25-ml cultures were harvested by centrifugation (5,000 ϫ g for 20 min at 4°C), resuspended in 3 ml of chilled HEPES buffer (100 mM [pH 7.4]), split into aliquots of 1.0 ml in 1.5-ml tubes, and centrifuged again (10,000 ϫ g for 3 min at 4°C). Then the cell pellet was resuspended in 100 l of GES buffer (5.0 M guanidium thiocyanate [GTC], 0.1 M EDTA, 0.5% Sarkosyl [pH 8.0]) and vortex-mixed for 10 s. Finally, the volume of the sample with intracellular extract was adjusted to 1.0 ml by adding 900 l of precooled Milli-Q water. Periplasmic flavin content was extracted according to previous reports (38, 39) . Briefly, cells harvested from 25-ml cultures (by centrifugation at 5,000 ϫ g for 20 min at 4°C) were resuspended in 3 ml of osmolysis buffer (18% sucrose, 2.5 mM EDTA, 100 mM Tris-HCl [pH 7.8]). The suspension was incubated gently at 50 rpm for 10 min, and the cells were harvested by centrifugation (13,000 ϫ g for 10 min at 4°C). The supernatant was discarded, and the cell pellet was resuspended in 3 ml of ice-cold Milli-Q water. The cell suspension was incubated in an ice bath for 10 min at 50 rpm, followed by centrifugation at 13,000 ϫ g for 10 min at 4°C. The supernatant contained the periplasmic fraction of E. coli cells. For ease of comparison, both the intracellular and periplasmic flavin levels were normalized to the protein concentrations of whole cells.
FAD hydrolysis assay. Subcellular fractions for enzyme activity assays were isolated and subjected to FAD hydrolysis assays as reported previously (33) . Briefly, cell fractions isolated with the lysozyme treatment method were aliquoted into a 96-well plate. The plate was prewarmed to 37°C, after which warm (37°C) FAD was added to each assay mixture to a final concentration of 115 M. Fluorescence (excitation at 440 nm and emission at 525 nm) was recorded immediately and at 5-min intervals at 37°C until no obvious increase in the fluorescence signals of all samples could be observed. The plate was gently shaken for 3 s before each data acquisition. Assuming that 1 mol of FAD was hydrolyzed to 1 mol of FMN, the increase in the fluorescence signal in response to FAD hydrolysis could be calculated based on standard solutions of FAD and FMN. The rate of FAD hydrolysis was determined by the slope of the initial linear segment of the fluorescence curve, which was normalized to the protein concentration of the sample.
Quantification of intracellular ATP contents. The intracellular ATP levels were determined by using a BacTiter-Glo microbial cell viability assay kit (Promega), following the manufacturer's instructions.
Flavin and xylose measurements. The cell lysate and supernatant samples for flavin quantification were filtered and measured using an ultra-performance liquid chromatography (UPLC) system (Shimadzu, Japan) equipped with a reverse-phase C 18 column (10 cm by 2.1 mm, 5 m; Ascentis) and a SPD-M20A diode array detector. A mixture of methanol and 0.05 M ammonium acetate (pH 6.0) was applied as the mobile phase, with controlled ratios as follows. A linear gradient from 25:75 to 70:30 (vol/vol) methanol/0.05 M ammonium acetate within 8 min was followed by isocratic elution at 70:30 (vol/vol) to 11 min and isocratic elution at 25:75 (vol/vol) to 16 min, at 30°C with a flow rate of 0.2 ml/min. 
GACCACCTTTTTTAGAAACTTCAGCACggatctggtcaaccagggttttc ushA-01_F7 GTGCTGAAGTTTCTAAAAAAGGTGGTCagaccctgctgctgtctgg (Continued on next page) 
Gene

Primer name Primer sequence a ushA-01_R7
ACACCGGTGTTGATGTCACCAccagacagcagcagggtct The elution times for FAD, FMN, and RF were 3.5 min, 4.6 min, and 6.1 min, respectively. Signals at 267 nm were used for calculations. For xylose quantification, sulfuric acid (5 mM) was utilized as the mobile phase, flowing at 0.6 ml/min through an Aminex HPX-87H column (Bio-Rad) at 50°C. The elution time for xylose was 9.3 min. The xylose concentration was calculated based on the absorbance signals at 190 nm for the samples and standard xylose solutions (31) .
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